TA
Trevor Allred Oppenheimer Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
11
Avg Return
Past Year
Past Year
25%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past Year
Positive
100%
Neutral
0%
Negative
0%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Healthcare
Healthcare
Biotechnology
| Stock | Rating | Price Target |
Upside Downside |
Ratings 1 Year |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
|
Outperform
Initiated
| $75 |
226%
upside
| 1 | +9.8% |
0
%
| 7 Jan ‘26 yesterday |
|
|
|
Outperform
Initiated
| $18 |
96%
upside
| 1 | +4.1% |
0
%
| 7 Jan ‘26 yesterday |
|
|
|
Outperform
Initiated
| $27 |
42%
upside
| 1 | +3.2% |
0
%
| 3 Dec ‘25 1 month ago |
|
|
|
Outperform
Maintained
| $250 |
25%
upside
| 4 | +19% |
0
%
| 3 Nov ‘25 2 months ago |
|
|
|
Outperform
Maintained
| $80 |
160%
upside
| 2 | +51% |
0
%
| 23 Sep ‘25 3 months ago |
|
|
|
Outperform
Initiated
| $85 |
13%
downside
| 1 | +77% |
0
%
| 9 Sep ‘25 4 months ago |
|
|
|
Outperform
Initiated
| $35 |
78%
upside
| 1 | +7.1% |
0
%
| 11 Aug ‘25 5 months ago |
|